Federal contract award
HHSO10033022T
NOVARTIS (SEQIRUS)- ANOTHER T/O FOR STABILITY - 5 YEAR + BULK PRODUCT.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 325414 — Biological Product (except Diagnostic) Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | HHSO100201200014I |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $0 |
| Current contract value | $0 |
| Potential contract value / ceiling | $0 |
| Start date | Jan 30, 2017 |
| Current end date | Aug 30, 2017 |
| Potential end date | Jan 9, 2025 |
| Latest award activity | Jan 8, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jan 8, 2025 | P00002 | $-402.1K | TO CLOSE THIS CONTRACT IN LINE WITH FAR 4.804, TO UPDATE THE CONTRACTING OFFICER TO DEVIN FITZMAURICE, AND TO DE-OBLIGATE $402,112.00 IN EXCESS FUNDS SO THE TOTAL OBLIGATION IS NOW $0.00. |
Research next steps
- Verify whether remaining options may extend performance beyond the current end date.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.